Clinical Trial Update: Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for newly diagnosed primary central nervous system lymphoma conducted in Nordic centers has completed enrollment and study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: University of Aarhus | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: COMPLETED